SG10201607344UA - A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof - Google Patents
A crystalline form of cyclosporine a, methods of preparation, and methods for use thereofInfo
- Publication number
- SG10201607344UA SG10201607344UA SG10201607344UA SG10201607344UA SG10201607344UA SG 10201607344U A SG10201607344U A SG 10201607344UA SG 10201607344U A SG10201607344U A SG 10201607344UA SG 10201607344U A SG10201607344U A SG 10201607344UA SG 10201607344U A SG10201607344U A SG 10201607344UA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- cyclosporine
- preparation
- crystalline form
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Analytical Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161490887P | 2011-05-27 | 2011-05-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201607344UA true SG10201607344UA (en) | 2016-10-28 |
Family
ID=46178866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201607344UA SG10201607344UA (en) | 2011-05-27 | 2012-05-25 | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US8772245B2 (de) |
| EP (2) | EP3521302A1 (de) |
| JP (1) | JP6163482B2 (de) |
| KR (1) | KR102079402B1 (de) |
| CN (1) | CN103649108B (de) |
| AR (1) | AR086586A1 (de) |
| AU (4) | AU2012262513B2 (de) |
| BR (1) | BR112013030554B1 (de) |
| CA (1) | CA2836946C (de) |
| CL (1) | CL2013003400A1 (de) |
| IL (2) | IL229475A0 (de) |
| MX (1) | MX362271B (de) |
| MY (1) | MY180581A (de) |
| RU (1) | RU2602062C2 (de) |
| SG (1) | SG10201607344UA (de) |
| TW (1) | TWI554522B (de) |
| UA (1) | UA113627C2 (de) |
| WO (1) | WO2012166610A1 (de) |
| ZA (1) | ZA201308665B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2779993B1 (de) | 2011-11-15 | 2018-04-04 | Allergan, Inc. | Autoklavierbare suspensionen von cyclosporin-a form 2 |
| CN108175742B (zh) * | 2011-11-15 | 2021-10-22 | 阿勒根公司 | 环孢菌素形式2的持续作用型制剂 |
| AU2012339693B2 (en) * | 2011-11-15 | 2017-09-07 | Allergan, Inc. | Cyclosporine A Form 2 and method of making same |
| AU2012339632A1 (en) * | 2011-11-15 | 2014-06-05 | Allergan, Inc. | Suspensions of cyclosporin A Form 2 |
| JP2015519368A (ja) | 2012-06-01 | 2015-07-09 | アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ | シクロスポリンａ類似体 |
| GB201222455D0 (en) * | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
| US10524661B2 (en) * | 2013-06-12 | 2020-01-07 | Proactive Live, Inc. | Sleep monitoring and stimulation |
| MY196111A (en) | 2014-07-18 | 2023-03-15 | Allergan Inc | Suspension Compositions of Cyclosporin a for Subconjunctival and Periocular Injection |
| US9914755B2 (en) | 2015-01-08 | 2018-03-13 | Allergan, Inc. | Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized |
| US10443292B2 (en) * | 2016-04-25 | 2019-10-15 | Magna Closures, Inc. | Non-contact obstacle detection system for motor vehicles |
| BR112019024040A2 (pt) * | 2017-05-17 | 2020-09-24 | Yuyu Pharma, Inc. | peptídeo e composição farmacêutica para tratamen-to de doenças oculares comprendendo o mesmo peptídeo como ingrediente ativo |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| WO2024085235A1 (ja) * | 2022-10-20 | 2024-04-25 | 中外製薬株式会社 | 環状ペプチドの結晶の製造方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203564B (en) * | 1987-12-21 | 1991-08-28 | Sandoz Ag | Process for producing new orthorombos cyclosporin without solvatation |
| GB9105705D0 (en) * | 1991-03-18 | 1991-05-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| US6254860B1 (en) * | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
| US6656504B1 (en) * | 1999-09-09 | 2003-12-02 | Elan Pharma International Ltd. | Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| BRPI0811538A2 (pt) * | 2007-05-04 | 2015-08-11 | Allergan Inc | Uso de ciclosporinas no tratamento de pacientes com lentes intraoculares. |
| BRPI0822221A2 (pt) * | 2008-01-04 | 2015-06-23 | Alcon Pharmaceuticals Ltd | Composições aquosas e estáveis de ciclosporina |
-
2012
- 2012-05-25 CN CN201280033382.7A patent/CN103649108B/zh active Active
- 2012-05-25 KR KR1020137034444A patent/KR102079402B1/ko active IP Right Grant
- 2012-05-25 CA CA2836946A patent/CA2836946C/en active Active
- 2012-05-25 US US13/480,710 patent/US8772245B2/en active Active
- 2012-05-25 RU RU2013155033/04A patent/RU2602062C2/ru active
- 2012-05-25 MY MYPI2013004226A patent/MY180581A/en unknown
- 2012-05-25 MX MX2013013855A patent/MX362271B/es active IP Right Grant
- 2012-05-25 EP EP18211911.5A patent/EP3521302A1/de not_active Withdrawn
- 2012-05-25 WO PCT/US2012/039611 patent/WO2012166610A1/en active Application Filing
- 2012-05-25 SG SG10201607344UA patent/SG10201607344UA/en unknown
- 2012-05-25 BR BR112013030554-1A patent/BR112013030554B1/pt active IP Right Grant
- 2012-05-25 JP JP2014512145A patent/JP6163482B2/ja active Active
- 2012-05-25 AU AU2012262513A patent/AU2012262513B2/en active Active
- 2012-05-25 EP EP12724525.6A patent/EP2714720B1/de active Active
- 2012-05-25 UA UAA201314231A patent/UA113627C2/uk unknown
- 2012-05-28 AR ARP120101878A patent/AR086586A1/es not_active Application Discontinuation
- 2012-05-28 TW TW101119051A patent/TWI554522B/zh active
-
2013
- 2013-11-17 IL IL229475A patent/IL229475A0/en unknown
- 2013-11-19 ZA ZA2013/08665A patent/ZA201308665B/en unknown
- 2013-11-26 CL CL2013003400A patent/CL2013003400A1/es unknown
-
2014
- 2014-07-02 US US14/322,475 patent/US9206228B2/en active Active
-
2015
- 2015-12-07 US US14/961,132 patent/US20160083432A1/en not_active Abandoned
-
2016
- 2016-06-15 AU AU2016203990A patent/AU2016203990A1/en not_active Abandoned
-
2017
- 2017-11-21 AU AU2017265008A patent/AU2017265008A1/en not_active Abandoned
-
2019
- 2019-06-14 AU AU2019204192A patent/AU2019204192B2/en active Active
-
2021
- 2021-01-13 US US17/148,315 patent/US20210269484A1/en not_active Abandoned
-
2022
- 2022-01-27 IL IL290158A patent/IL290158A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290158A (en) | Crystal structure of cyclosporin a, methods of preparation, and methods of using it | |
| EP2744331A4 (de) | Verfahren und zwischenprodukte zur herstellung von makrolactamen | |
| HUE037674T2 (hu) | Eljárás uliprisztál-acetát és intermedierjének elõállítására | |
| EP2796442A4 (de) | Analoger verbundstoff aus einer cajaninstruktur, herstellungsverfahren dafür und verwendung davon | |
| ZA201306316B (en) | Methods and compositions for preparing noribogaine from voacangine | |
| HK1213894A1 (zh) | 埃克替尼和鹽酸埃克替尼的製備方法及其中間體 | |
| EP2691397A4 (de) | Verfahren und zusammensetzungen zur herstellung von noribogain aus voacangin | |
| GB201110042D0 (en) | Growth of cells | |
| EP2682390A4 (de) | 2-aminothiazol-derivat, verfahren zu seiner herstellung und verwendung davon | |
| IL225972A0 (en) | Salts of cocuamine b, a method for their preparation and use | |
| PL2785701T3 (pl) | Krystaliczna postać kabazytakselu i sposób jej otrzymywania | |
| EP2718331A4 (de) | N,n,n-trialkylpolymere, verfahren zu ihrer herstellung und ihre verwendung | |
| EP2718304A4 (de) | Verfahren zur herstellung eines ethylen-alpha-olefin-dien-copolymers | |
| EP2731429A4 (de) | Verbindungen, herstellungsverfahren dafür und verwendungsverfahren dafür | |
| EP2763998A4 (de) | Tri-heterocyclische derivate, herstellungsverfahren und verwendungen dafür | |
| EP2762167A4 (de) | Einfach einnehmbares feststoffpräparat | |
| PL3210991T3 (pl) | Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie | |
| EP2759529A4 (de) | Verfahren zur herstellung von 1-palmitoyl-3-acetylglycerol und verfahren zur herstellung von 1-palmitoyl-2-linoleoyl-3-acetylglycerol damit | |
| EP2671878A4 (de) | Substituierte n-pentanamid-verbindungen, herstellungsverfahren dafür und verwendungen davon | |
| IL227711A0 (en) | Phenyl-isoxazole history and their preparation process | |
| EP2698159A4 (de) | Pitavastatinhaltiges präparat und herstellungsverfahren dafür | |
| EP2738159A4 (de) | Mercaptobenzophenonverbindungen sowie zusammensetzungen daraus und herstellungsverfahren dafür | |
| HK1216249A1 (zh) | 比馬前列素酸的結晶形式、其製備方法和使用方法 | |
| EP2752419A4 (de) | Spirobenzylamin-phosphin, verfahren zu seiner herstellung und verwendung davon | |
| EP2684869A4 (de) | Herstellung von 3-mercaptopropionaten |